For: | Kolnagou A, Kontoghiorghe CN, Kontoghiorghes GJ. Transition of Thalassaemia and Friedreich ataxia from fatal to chronic diseases. World J Methodol 2014; 4(4): 197-218 [PMID: 25541601 DOI: 10.5662/wjm.v4.i4.197] |
---|---|
URL: | https://www.wjgnet.com/2222-0682/full/v4/i4/197.htm |
Number | Citing Articles |
1 |
Tahani Mohammed Manea, Faris Suhail Abdalhameed Khan, Renad Mohammed Alsharyufi, Kholoud Mohammed Alghamdi, Manal Khalaf Alzahrani, Fawaz Mohammed Alzubaidi, Ali Abdulaziz Alghanmi, Turki Abdullah Almahdawi, Turki Mohammed Alhasani, Nermeen Nasser Alrajhi. An Overview on Thalassemia Diagnosis and Management Approach, Literature Review. International Journal Of Pharmaceutical Research And Allied Sciences 2021; 10(2): 103 doi: 10.51847/JOXooiGiVQ
|
2 |
Wasim Sajjad, Mahnoor Nadeem, Tayyaba Alam, Asim ur Rehman, Sumra Wajid Abbasi, Sajjad Ahmad, Ghufranud Din, Samiullah Khan, Malik Badshah, Sarah Gul, Muhammad Farman, Aamer Ali Shah. Biological Evaluation and Computational Studies of Methoxy-flavones from Newly Isolated Radioresistant Micromonospora aurantiaca Strain TMC-15. Applied Biochemistry and Biotechnology 2023; 195(8): 4915 doi: 10.1007/s12010-023-04517-7
|
3 |
George J. Kontoghiorghes. Deferiprone and Iron–Maltol: Forty Years since Their Discovery and Insights into Their Drug Design, Development, Clinical Use and Future Prospects. International Journal of Molecular Sciences 2023; 24(5): 4970 doi: 10.3390/ijms24054970
|
4 |
Hala A. Al-Kherbash, Ahmed Al-Awdi, Nawal S. Hasan. Pattern and clinical profile of thalassemia among pediatric patients attending the Yemeni Society Centers for Thalassemia and Genetic Blood Disorders in Yemen. The Scientific Journal of Al-Azhar Medical Faculty, Girls 2017; 1(2): 43 doi: 10.4103/sjamf.sjamf_15_17
|
5 |
George J. Kontoghiorghes. Advances on Chelation and Chelator Metal Complexes in Medicine. International Journal of Molecular Sciences 2020; 21(7): 2499 doi: 10.3390/ijms21072499
|
6 |
Christina N Kontoghiorghe, George J Kontoghiorghes. New developments and controversies in iron metabolism and iron chelation therapy. World Journal of Methodology 2016; 6(1): 1-19 doi: 10.5662/wjm.v6.i1.1
|
7 |
George J. Kontoghiorghes. The Vital Role Played by Deferiprone in the Transition of Thalassaemia from a Fatal to a Chronic Disease and Challenges in Its Repurposing for Use in Non-Iron-Loaded Diseases. Pharmaceuticals 2023; 16(7): 1016 doi: 10.3390/ph16071016
|
8 |
George J. Kontoghiorghes. Drug Selection and Posology, Optimal Therapies and Risk/Benefit Assessment in Medicine: The Paradigm of Iron-Chelating Drugs. International Journal of Molecular Sciences 2023; 24(23): 16749 doi: 10.3390/ijms242316749
|
9 |
Qi Li, Zeyuan Chen, Xiaoshi Zhou, Guolin Li, Changji Zhang, Yong Yang. Ferroptosis and multi-organ complications in COVID-19: mechanisms and potential therapies. Frontiers in Genetics 2023; 14 doi: 10.3389/fgene.2023.1187985
|
10 |
Amani Abu-Shaheen, Humariya Heena, Abdullah Nofal, Doaa A. Abdelmoety, Abdulrahman Almatary, Mohammed Alsheef, Isamme AlFayyad, Mittal Suneeta. Epidemiology of Thalassemia in Gulf Cooperation Council Countries: A Systematic Review. BioMed Research International 2020; 2020(1) doi: 10.1155/2020/1509501
|
11 |
George J. Kontoghiorghes. The aim of iron chelation therapy in thalassaemia. European Journal of Haematology 2017; 99(5): 465 doi: 10.1111/ejh.12939
|
12 |
George J. Kontoghiorghes. The Importance and Essentiality of Natural and Synthetic Chelators in Medicine: Increased Prospects for the Effective Treatment of Iron Overload and Iron Deficiency. International Journal of Molecular Sciences 2024; 25(9): 4654 doi: 10.3390/ijms25094654
|
13 |
Annita Kolnagou, Marios Kleanthous, George J. Kontoghiorghes. Benefits and Risks in Polypathology and Polypharmacotherapy Challenges in the Era of the Transition of Thalassaemia from a Fatal to a Chronic or Curable Disease. Frontiers in Bioscience-Elite 2022; 14(3) doi: 10.31083/j.fbe1403018
|
14 |
Petr Dusek, Susanne A. Schneider, Jan Aaseth. Iron chelation in the treatment of neurodegenerative diseases. Journal of Trace Elements in Medicine and Biology 2016; 38: 81 doi: 10.1016/j.jtemb.2016.03.010
|
15 |
Ruiying Cheng, Rajitha Gadde, Yingfang Fan, Neha Kulkarni, Nachiket Shevale, Kai Bao, Hak Soo Choi, Swati Betharia, Jonghan Kim. Reversal of genetic brain iron accumulation by N,N′-bis(2-mercaptoethyl)isophthalamide, a lipophilic metal chelator, in mice. Archives of Toxicology 2022; 96(7): 1951 doi: 10.1007/s00204-022-03287-1
|
16 |
Christina Kontoghiorghe, Annita Kolnagou, George Kontoghiorghes. Phytochelators Intended for Clinical Use in Iron Overload, Other Diseases of Iron Imbalance and Free Radical Pathology. Molecules 2015; 20(11): 20841 doi: 10.3390/molecules201119725
|
17 |
George J. Kontoghiorghes. The Puzzle of Aspirin and Iron Deficiency: The Vital Missing Link of the Iron-Chelating Metabolites. International Journal of Molecular Sciences 2024; 25(10): 5150 doi: 10.3390/ijms25105150
|
18 |
Petr Dusek, Jan Aaseth. Chelation Therapy in the Treatment of Metal Intoxication. 2016; : 285 doi: 10.1016/B978-0-12-803072-1.00006-7
|
19 |
George Kontoghiorghes, Christina Kontoghiorghe. Iron and Chelation in Biochemistry and Medicine: New Approaches to Controlling Iron Metabolism and Treating Related Diseases. Cells 2020; 9(6): 1456 doi: 10.3390/cells9061456
|
20 |
Martin B. Delatycki, Fowzan Alkuraya, Alison Archibald, Carlo Castellani, Martina Cornel, Wayne W. Grody, Lidewij Henneman, Adonis S. Ioannides, Edwin Kirk, Nigel Laing, Anneke Lucassen, John Massie, Juliette Schuurmans, Meow‐Keong Thong, Irene van Langen, Joël Zlotogora. International perspectives on the implementation of reproductive carrier screening. Prenatal Diagnosis 2020; 40(3): 301 doi: 10.1002/pd.5611
|
21 |
George J Kontoghiorghes, Christina N Kontoghiorghe. Prospects for the introduction of targeted antioxidant drugs for the prevention and treatment of diseases related to free radical pathology. Expert Opinion on Investigational Drugs 2019; 28(7): 593 doi: 10.1080/13543784.2019.1631284
|